NO20054854D0 - Femrings heterocykliske derivater - Google Patents
Femrings heterocykliske derivaterInfo
- Publication number
- NO20054854D0 NO20054854D0 NO20054854A NO20054854A NO20054854D0 NO 20054854 D0 NO20054854 D0 NO 20054854D0 NO 20054854 A NO20054854 A NO 20054854A NO 20054854 A NO20054854 A NO 20054854A NO 20054854 D0 NO20054854 D0 NO 20054854D0
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic derivatives
- ring heterocyclic
- ring
- derivatives
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/499—Spiro-condensed pyrazines or piperazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003115204 | 2003-04-21 | ||
JP2004042859 | 2004-02-19 | ||
PCT/JP2004/005605 WO2004094407A1 (ja) | 2003-04-21 | 2004-04-20 | 5員複素環誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054854D0 true NO20054854D0 (no) | 2005-10-20 |
NO20054854L NO20054854L (no) | 2005-11-15 |
Family
ID=33312607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054854A NO20054854L (no) | 2003-04-21 | 2005-10-20 | Femrings heterocykliske derivater |
Country Status (12)
Country | Link |
---|---|
US (1) | US20060189591A1 (no) |
EP (1) | EP1621537A4 (no) |
JP (1) | JPWO2004094407A1 (no) |
KR (1) | KR20060005378A (no) |
AU (1) | AU2004232577A1 (no) |
CA (1) | CA2522536A1 (no) |
MX (1) | MXPA05011276A (no) |
NO (1) | NO20054854L (no) |
PL (1) | PL378841A1 (no) |
RU (1) | RU2005135927A (no) |
TW (1) | TW200504049A (no) |
WO (1) | WO2004094407A1 (no) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1591443B1 (en) * | 2003-02-07 | 2010-08-25 | Daiichi Sankyo Company, Limited | Pyrazole derivative |
EP1762568A1 (en) * | 2004-07-01 | 2007-03-14 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivatives |
EP1775293A4 (en) * | 2004-08-06 | 2009-09-16 | Daiichi Seiyaku Co | Antithrombocytochemicals and process for their preparation |
CA2578261A1 (en) * | 2004-08-06 | 2006-02-09 | Daiichi Pharmaceutical Co., Ltd. | Pyrazole derivative |
ZA200703562B (en) * | 2004-10-19 | 2008-08-27 | Daiichi Seiyaku Co | 1,5-diheterocycle-1H-triazole derivative |
UA85937C2 (uk) | 2004-12-21 | 2009-03-10 | Пфайзер Продактс Інк. | Макроліди |
US8084451B2 (en) * | 2005-01-10 | 2011-12-27 | University Of Connecticut | Heteropyrrole analogs acting on cannabinoid receptors |
JP2009533445A (ja) | 2006-04-14 | 2009-09-17 | メルク エンド カムパニー インコーポレーテッド | コレシストキニン−1受容体モジュレータとしての置換イミダゾール4−カルボキサミド |
DE602007007594D1 (de) | 2006-04-14 | 2010-08-19 | Merck Sharp & Dohme | Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren |
NZ571412A (en) | 2006-04-14 | 2010-07-30 | Merck & Co Inc | Substituted imidazole 4-carboximides as cholecystokinin-1 receptor modulators |
AU2008209472A1 (en) | 2007-01-26 | 2008-07-31 | Merck Sharp & Dohme Corp. | Substituted aminopyrimidines as cholecystokinin-1 receptor modulators |
EP2298778A4 (en) | 2008-06-12 | 2011-10-05 | Daiichi Sankyo Co Ltd | IMIDAZOTHIAZOL DERIVATIVE WITH 4,7-DIAZASPIRO [2.5] OCTAN RING STRUCTURE |
JO3215B1 (ar) * | 2012-08-09 | 2018-03-08 | Phenex Pharmaceuticals Ag | حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy |
CA3125847A1 (en) | 2020-07-27 | 2022-01-27 | Makscientific, Llc | Process for making biologically active compounds and intermediates thereof |
US12054480B2 (en) | 2020-07-31 | 2024-08-06 | Makscientific, Llc | Compounds for treating cannabinoid toxicity and acute cannabinoid overdose |
WO2024009283A1 (en) * | 2022-07-07 | 2024-01-11 | University Of Southern California | At2 antagonists for non-addictive pain relief |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1043805B (it) * | 1970-03-05 | 1980-02-29 | Serono Ist Farm | Ammidi e idrazidi di acidi carbos silici derivanti dal 4,5,difenilossazolo e processo per la loro preparazione |
JP3003148B2 (ja) * | 1989-01-05 | 2000-01-24 | 藤沢薬品工業株式会社 | チアゾール化合物、その製造法およびそれを含有する医薬組成物 |
FR2714057B1 (fr) * | 1993-12-17 | 1996-03-08 | Sanofi Elf | Nouveaux dérivés du 3-pyrazolecarboxamide, procédé pour leur préparation et compositions pharmaceutiques les contenant. |
US5559137A (en) * | 1994-05-16 | 1996-09-24 | Smithkline Beecham Corp. | Compounds |
US6492516B1 (en) * | 1999-05-14 | 2002-12-10 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
US20040077697A1 (en) * | 2001-02-02 | 2004-04-22 | Hiroyuki Koshio | 2-Acylaminothiazole derivative or its salt |
TWI231757B (en) * | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
PE20030547A1 (es) * | 2001-09-24 | 2003-08-18 | Bayer Corp | Derivados de imidazol para el tratamiento de la obesidad |
US7319110B2 (en) * | 2002-09-19 | 2008-01-15 | Solvay Pharmaceuticals B.V. | 1H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activity |
WO2004060367A1 (en) * | 2002-12-30 | 2004-07-22 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole and triazole derivatives useful as selective cox-1 inhibitors |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
US20050026983A1 (en) * | 2003-07-30 | 2005-02-03 | Pfizer Inc | Imidazole compounds and uses thereof |
FR2866340B1 (fr) * | 2004-02-13 | 2006-11-24 | Sanofi Synthelabo | Derives d'oxazole, leur preparation et leur utilisation en therapeutique. |
ZA200703562B (en) * | 2004-10-19 | 2008-08-27 | Daiichi Seiyaku Co | 1,5-diheterocycle-1H-triazole derivative |
-
2004
- 2004-04-20 WO PCT/JP2004/005605 patent/WO2004094407A1/ja active Application Filing
- 2004-04-20 KR KR1020057019888A patent/KR20060005378A/ko not_active Application Discontinuation
- 2004-04-20 EP EP04728462A patent/EP1621537A4/en not_active Withdrawn
- 2004-04-20 RU RU2005135927/04A patent/RU2005135927A/ru not_active Application Discontinuation
- 2004-04-20 US US10/553,982 patent/US20060189591A1/en not_active Abandoned
- 2004-04-20 MX MXPA05011276A patent/MXPA05011276A/es unknown
- 2004-04-20 CA CA002522536A patent/CA2522536A1/en not_active Abandoned
- 2004-04-20 PL PL378841A patent/PL378841A1/pl unknown
- 2004-04-20 AU AU2004232577A patent/AU2004232577A1/en not_active Abandoned
- 2004-04-20 JP JP2005505738A patent/JPWO2004094407A1/ja not_active Withdrawn
- 2004-04-21 TW TW093111154A patent/TW200504049A/zh unknown
-
2005
- 2005-10-20 NO NO20054854A patent/NO20054854L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2005135927A (ru) | 2006-05-10 |
TW200504049A (en) | 2005-02-01 |
KR20060005378A (ko) | 2006-01-17 |
EP1621537A4 (en) | 2008-12-31 |
CA2522536A1 (en) | 2004-11-04 |
AU2004232577A1 (en) | 2004-11-04 |
NO20054854L (no) | 2005-11-15 |
WO2004094407A1 (ja) | 2004-11-04 |
MXPA05011276A (es) | 2006-01-24 |
JPWO2004094407A1 (ja) | 2006-07-13 |
PL378841A1 (pl) | 2006-05-29 |
US20060189591A1 (en) | 2006-08-24 |
EP1621537A1 (en) | 2006-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054854D0 (no) | Femrings heterocykliske derivater | |
IS8348A (is) | Samrunnin heteróhringasambönd | |
CY2015036I1 (el) | Νεα παραγωγα οξαζολιδινονης | |
DK1594840T3 (da) | Piperidin-benzensulfonamid-derivater | |
NO20054136D0 (no) | Imidazol-4-yl-etynyl-pyridin-derivater | |
DK1682493T3 (da) | Amidoacetonitrilderivater | |
IS8180A (is) | Nýjar besímídasólafleiður | |
ATE352550T1 (de) | Chinazolinderivate | |
ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
ATE450506T1 (de) | Indol-3-schwefelderivate | |
ATE467631T1 (de) | Chinuclidinamidderivate | |
ATE438644T1 (de) | Chinazolinderivate | |
DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
ATE499347T1 (de) | Amidderivate | |
DE602004015724D1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
DE602004024420D1 (de) | Chinazolinderivate als antitumormittel | |
IS8364A (is) | N-þíasól-2-ýl-bensamíð afleiður | |
DE602004019555D1 (de) | Heterocyclische 7-aminoalkylidenylchinolone und -naphthyridone | |
IS7833A (is) | Efnasambönd með sameinaða heteróhringi | |
DK1652843T3 (da) | Amidderivater | |
IS8045A (is) | Púrín-6-ón-afleiður | |
ATE335729T1 (de) | 3h-chinazoline -4-on derivaten | |
NO20070299L (no) | Novel heterocyclic compounds | |
DE602004007387D1 (de) | 5-substituierte chinazolinonderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |